반응식
[NH2:1][C@H:2]([C:8]([O-:10])=[O:9])[CH2:3][CH2:4][C:5]([OH:7])=[O:6].[Na+:11].[NH2:12][C@H:13]([C:18]([O-:20])=[O:19])[CH2:14][C:15]([OH:17])=[O:16].[Na+].[OH-].[Al+3].[OH-].[OH-]>O>[NH2:1][C@H:2]([C:8]([O-:10])=[O:9])[CH2:3][CH2:4][C:5]([OH:7])=[O:6].[Na+:11].[NH2:12][C@H:13]([C:18]([O-:20])=[O:19])[CH2:14][C:15]([OH:17])=[O:16].[Na+:11]참가 물질
5
실험 절차
A solution of 50% by weight (total) of a mixture of monosodium glutamate (MSG) and monosodium aspartate (MSA) in equal molar ratio, is prepared in water and an active biological agent (in this example hepatitis B/aluminium hydroxide adjuvanted vaccine) added in a quantity to give a final MSG/MSA to adjuvant ratio of 40:1.
출처 및 근거
- ORD 기록
- ord-7ab8edc9b30140f7a9f521ad576d3f85
- 출처 데이터셋
- uspto-grants-2014_09
- 특허 번호
- US08821437B2
연결된 노트
불러오는 중…